SDBody

SDBody operates as a physician-supervised peptide therapy clinic in San Diego, California, focusing on body composition optimization, metabolic enhancement, and performance recovery through targeted peptide protocols. The clinic structures treatment around growth hormone secretagogues including ipamorelin and CJC-1295, BPC-157 for tissue repair and gut health, and metabolic peptides such as AOD-9604 and tesofensine for fat reduction. Each protocol begins with comprehensive laboratory assessment including IGF-1, metabolic panels, hormone profiles, and body composition analysis to establish baseline metrics and guide peptide selection.

The clinic's peptide offerings address specific physiological goals: growth hormone secretagogues for muscle preservation and recovery, BPC-157 administered at 250-500 mcg dosing for tendon injuries and inflammatory bowel conditions, thymosin beta-4 for wound healing and tissue regeneration, and GLP-1 agonists including semaglutide for appetite regulation and weight management. SDBody sources peptides from FDA-registered compounding pharmacies and provides detailed injection training for subcutaneous administration. Treatment protocols typically run 12-16 weeks with laboratory monitoring at 6-week intervals to assess IGF-1 response, metabolic markers, and body composition changes measured through DEXA scanning or bioimpedance analysis.

Medical oversight at SDBody includes initial consultation to review health history, current medications, and treatment objectives, followed by laboratory ordering and results interpretation. The clinic evaluates contraindications including active malignancy, uncontrolled diabetes, and proliferative retinopathy before initiating growth hormone secretagogue therapy. Providers adjust peptide dosing based on individual response patterns, side effect profiles, and laboratory trends. Patients receive written protocols specifying peptide reconstitution instructions, injection timing relative to meals and exercise, and storage requirements for maintaining peptide stability.

Patients at the San Diego clinic typically present for muscle preservation during caloric restriction, recovery from orthopedic injuries, metabolic syndrome management, or age-related body composition changes. Initial visits include physical examination, body composition measurement, and discussion of realistic timelines for peptide response—generally 4-8 weeks for growth hormone secretagogue effects on sleep and recovery, 6-12 weeks for body composition changes, and 2-4 weeks for BPC-157 effects on acute injuries. The clinic provides ongoing communication through patient portal messaging for questions about injection technique, side effects such as water retention or injection site reactions, and protocol adjustments based on progress.

SDBody serves patients throughout San Diego County with in-person visits required for initial consultation and periodic follow-up assessments. The clinic coordinates with patients' primary care providers when appropriate and provides documentation of peptide therapy for medical records. Treatment costs are structured as consultation fees, laboratory fees through contracted reference labs, and peptide costs based on specific compounds and dosing protocols selected. The clinic does not accept insurance for peptide therapy services but provides itemized invoices for HSA/FSA reimbursement and superbills for patients seeking out-of-network reimbursement.